Condition: Alzheimer Disease · Sponsor: University of the Philippines
This study will explore the different factors associated with drug response to acetylcholinesterase (AChE) inhibitor (donepezil) and NMDA receptor antagonist (memantine) in patients with Alzheimer's Disease.
This description comes directly from the study's public registry record.
Fresthel Monica M Climacosa, MD, PhD · +639434744737 · fmclimacosa@up.edu.ph
Veeda Michelle M Anlacan, MD · +639189197143 · vmanlacan@up.edu.ph
Always discuss trial participation with your own doctor first.
| Philippine General Hospital | Manila, National Capital Region, Philippines | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05801380